Getting real about valuations in biotech
- 1 April 2005
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 23 (4) , 423-428
- https://doi.org/10.1038/nbt0405-423
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- The Distribution of Sales Revenues from Pharmaceutical InnovationPharmacoEconomics, 2000